It’s a good day to be CVS, as the pharmacy giant officially announced its planned $10.6 billion acquisition of Oak Street Health and beat Q4 earnings estimates.

Why it matters: CVS has not one but two deals now pending, valued at a combined total of $18.5 billion, and it’s already getting antitrust pushback.

…

• Other receptions weren’t as rosy: “This deal will be especially disastrous for seniors, who will have little choice but to rely on CVS’s notoriously poor customer service model combined with Oak Street’s physician practices, which have reportedly been staffed without any doctor on site,” the American Economic Liberties Project said yesterday in a statement.
• “The Federal Trade Commission should immediately look to block it,” the statement added.

The bottom line: The company’s lawyers and accountants will be busy juggling all of the above.